These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9402352)

  • 1. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer.
    Carpintero P; Blanco M; Pajares JM
    Clin Infect Dis; 1997 Nov; 25(5):1032-7. PubMed ID: 9402352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
    Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.
    Archimandritis A; Balatsos V; Delis V; Mentis A; Kastanas K; Scandalis N
    J Clin Gastroenterol; 1995 Jan; 20(1):12-6. PubMed ID: 7884169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
    Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three treatment schemes with colloidal bismuth subcitrate (Q-ULCER) in peptic ulcer with Helicobacter pylori.
    Suárez MS; González Cansino J; Velasco Ilizalde C; Sabatier CA; Castillo Hernández J
    Arch Med Res; 1999; 30(1):55-9. PubMed ID: 10071426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
    Marchi S; Costa F; Bellini M; Belcari C; Mumolo MG; Tornar A; Spisni R; Torelli E; Maltinti G
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):547-50. PubMed ID: 11396535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group.
    Seppälä K; Pikkarainen P; Sipponen P; Kivilaakso E; Gormsen MH
    Gut; 1995 Jun; 36(6):834-7. PubMed ID: 7615269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
    Hentschel E; Brandstätter G; Dragosics B; Hirschl AM; Nemec H; Schütze K; Taufer M; Wurzer H
    N Engl J Med; 1993 Feb; 328(5):308-12. PubMed ID: 8419816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
    Nie Y; Li Y; Wu H; Sha W; Du H; Dai S; Wang H; Li Q
    Helicobacter; 1999 Jun; 4(2):128-34. PubMed ID: 10382127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
    Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
    Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up.
    Goh KL; Navaratnam P; Peh SC
    Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1157-60. PubMed ID: 8980932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal bismuth subcitrate, ranitidine, and ranitidine plus metronidazole in the treatment of duodenal ulcer and Helicobacter pylori infection: a controlled and prospective study.
    Huang CK; Chen GH
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jul; 52(1):15-20. PubMed ID: 8364776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
    Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
    Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
    Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients.
    Seppälä K; Färkkilä M; Nuutinen H; Hakala K; Väänänen H; Rautelin H; Kosunen TU
    Scand J Gastroenterol; 1992 Nov; 27(11):973-6. PubMed ID: 1455197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.